Accellacare is enrolling adults who display COVID-19 symptoms, but are not at risk for severe illness. Eligible participants will receive study-related care and medication at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare is enrolling a research study for current e-cigarettes, vape, Juul, e-pen users to evaluate an ENDS. Eligible participants will receive financial compensation of for time and travel and access to ENDS for the duration of the study.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
News & Insights:
Developing vaccines started over 200 years ago when Dr. Edward Jenner created the first vaccine designed to immunize against smallpox. In 1980, the World Health Organization (WHO) determined that smallpox, a disease that killed over 35% of its victims, was eradicated worldwide.
World Parkinson’s Day is celebrated on the 11th of April each year and it’s a day set aside to raise awareness of the reality of Parkinson’s disease and how it affects individuals and their families.
Nothing excites us more than talking with one of our patients. We asked retired Obstetrician Dr. Michael Hoffman, who participated in an RSV vaccine study, to answer a few questions for us. This is what he had to say.